PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ADMA vs. SMMT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ADMA and SMMT is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

ADMA vs. SMMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and Summit Therapeutics Inc. (SMMT). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%JulyAugustSeptemberOctoberNovemberDecember
65.27%
117.67%
ADMA
SMMT

Key characteristics

Sharpe Ratio

ADMA:

5.00

SMMT:

1.98

Sortino Ratio

ADMA:

5.31

SMMT:

5.32

Omega Ratio

ADMA:

1.72

SMMT:

1.70

Calmar Ratio

ADMA:

4.87

SMMT:

6.93

Martin Ratio

ADMA:

41.36

SMMT:

23.80

Ulcer Index

ADMA:

7.92%

SMMT:

24.80%

Daily Std Dev

ADMA:

65.45%

SMMT:

298.37%

Max Drawdown

ADMA:

-91.28%

SMMT:

-95.75%

Current Drawdown

ADMA:

-21.75%

SMMT:

-46.82%

Fundamentals

Market Cap

ADMA:

$4.40B

SMMT:

$13.78B

EPS

ADMA:

$0.27

SMMT:

-$0.23

PEG Ratio

ADMA:

0.00

SMMT:

0.00

Total Revenue (TTM)

ADMA:

$382.81M

SMMT:

-$235.00K

Gross Profit (TTM)

ADMA:

$186.78M

SMMT:

-$907.00K

EBITDA (TTM)

ADMA:

$98.48M

SMMT:

-$184.77M

Returns By Period

In the year-to-date period, ADMA achieves a 291.59% return, which is significantly lower than SMMT's 550.57% return.


ADMA

YTD

291.59%

1M

-9.42%

6M

66.67%

1Y

319.43%

5Y*

33.27%

10Y*

5.32%

SMMT

YTD

550.57%

1M

-10.54%

6M

113.85%

1Y

533.58%

5Y*

63.72%

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ADMA vs. SMMT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ADMA, currently valued at 5.00, compared to the broader market-4.00-2.000.002.005.001.98
The chart of Sortino ratio for ADMA, currently valued at 5.31, compared to the broader market-4.00-2.000.002.004.005.315.32
The chart of Omega ratio for ADMA, currently valued at 1.72, compared to the broader market0.501.001.502.001.721.70
The chart of Calmar ratio for ADMA, currently valued at 5.60, compared to the broader market0.002.004.006.005.606.93
The chart of Martin ratio for ADMA, currently valued at 41.36, compared to the broader market0.0010.0020.0041.3623.80
ADMA
SMMT

The current ADMA Sharpe Ratio is 5.00, which is higher than the SMMT Sharpe Ratio of 1.98. The chart below compares the historical Sharpe Ratios of ADMA and SMMT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.002.004.006.008.00JulyAugustSeptemberOctoberNovemberDecember
5.00
1.98
ADMA
SMMT

Dividends

ADMA vs. SMMT - Dividend Comparison

Neither ADMA nor SMMT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ADMA vs. SMMT - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, roughly equal to the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for ADMA and SMMT. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-21.75%
-46.82%
ADMA
SMMT

Volatility

ADMA vs. SMMT - Volatility Comparison

The current volatility for ADMA Biologics, Inc. (ADMA) is 15.02%, while Summit Therapeutics Inc. (SMMT) has a volatility of 17.80%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%50.00%100.00%150.00%JulyAugustSeptemberOctoberNovemberDecember
15.02%
17.80%
ADMA
SMMT

Financials

ADMA vs. SMMT - Financials Comparison

This section allows you to compare key financial metrics between ADMA Biologics, Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab